Scienture Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Scienture Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Scienture Holdings Inc SCNX.OQ reported a quarterly adjusted loss of 7 cents per share for the quarter ended June 30. The lone analyst forecast for the quarter was for a loss of 23 cents per share.
Revenue was $343.00 thousand; analysts expected zero.
Scienture Holdings Inc's reported EPS for the quarter was a loss of 7 cents.
The company reported a quarterly loss of $2.82 million.
Scienture Holdings Inc shares had risen by 28.6% this quarter and lost 11.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Scienture Holdings Inc is $1.50, about 70% above its last closing price of $0.45
This summary was machine generated from LSEG data August 13 at 09:17 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.23 | -0.07 | Beat |
Mar. 31 2026 | -0.22 | -0.08 | Beat |
Dec. 31 2025 | -0.28 | -0.11 | Beat |